CIK 0001672619
- Non-accelerated filer
Enliven Therapeutics, Inc.
Sign in to watch- Ticker
- ELVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811523849
- Phone
- +1 650-547-5814
- Business address
- 205 PARK ROAD, BURLINGAME, CA, 94010
- Former names
- IMARA Inc.
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $20.41 ($66,327)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CHIEF OPERATING OFFICER sold 6,667 shares at $21.93 ($146,206)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $22.52 ($22,524)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 3,250 shares at $21.59 ($70,178)
- 4 Planned sale CHIEF OPERATING OFFICER sold 28,367 shares at an average $24.18 ($685,868)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 1,000 shares at $25.04 ($25,039)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 4,250 shares at an average $22.23 ($94,474)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 5,250 shares at an average $24.89 ($130,688)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 6,250 shares at an average $28.56 ($178,485)
Page 6 of 20 · 383 filings